U.S. Markets open in 7 hrs 21 mins

Akers Biosciences, Inc. (AKR.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
80.000.00 (0.00%)
At close: 4:30PM BST
People also watch
AMS.LAOR.LAGY.LAFN.LAPH.L

Akers Biosciences, Inc.

201 Grove Road
Thorofare, NJ 08086
United States
856-848-8698
http://www.akersbio.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees28

Key Executives

NameTitlePayExercisedAge
Mr. John J. GormallyCEO & Director256.3kN/A61
Dr. Raymond F. Akers Jr., Ph.D.Co-Founder, Vice Chairman, Sec. & Chief Scientific Director277.03kN/A59
Mr. Gary M. RauchVP - Fin. & Treasurer95kN/A61
Mr. Douglas CarraraVP of Global Marketing & Commercial OperationsN/AN/AN/A
Mr. Tony SaporitoVP of US Sales & DistributionN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States and internationally. The company’s marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness. Its marketed products also include PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol ‘Check’, a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek, a breath test for oxidative stress using the Lync reader and digital app. The company’s pipeline products comprise Breath Diabetic Ketoacidosis, a disposable breath ketone device for diabetic monitoring; Breath PulmoHealth ‘Check’, a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; PIFA PLUSS Chlamydia, a rapid test for sexually transmitted diseases; and BreathScan KetoChek, a breath test for ketosis using the Lync reader and digital app. Akers Biosciences, Inc. was founded in 1989 and is headquartered in Thorofare, New Jersey.

Corporate Governance

Akers Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.